A study on ascorbate inhibition of ceruloplasmin ferroxidase activity

BioMetals

Volumn 10, Issue 2, 1997, Pages 123-126

  Løvstad, Rolf Arthur ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Ascorbate; Ceruloplasmin; Conalbumin; Iron ions; Transferrin

Indexed keywords

ASCORBIC ACID; CERULOPLASMIN; FERRIC ION; TRANSFERRIN;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; PH;

EID: 0030998669     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018383207608     Document Type: Article

References (17)

1. Baldwin DA, De Sousa DMR, von Wandruszka RMA. 1982 The effect of pH on the kinetics of iron release from human transferrin. Biochim Biophys Acta 719, 140-146.
2. Carver, FJ, Frieden E. 1978 Factors affecting the adenosine triphosphate induced release of iron from transferrin. Biochemistry 17, 167-172.
3. Carver FJ, Farb DL, Frieden E. 1982 The effect of albumin, ceruloplasmin, and other serum constituents on Fe(II) oxidation. Biol Trace Element Res 4, 1-19.
4. Frieden E, Hsieh HS. 1976 Ceruloplasmin: the copper transport protein with essential oxidase activity. Adv Enzymol 44, 187-236.
5. Gutteridge JMC. 1978 Caeruloplasmin: a plasma protein, enzyme, and antioxidant. Ann Clin Biochem 15, 293-296.
6. Gutteridge JMC. 1985 Inhibition of the Fenton reaction by the protein caeruloplasmin and other copper complexes. Assessment of ferroxidase and radical scavenging activities. Chem-Biol Interact 56, 113-120.
7. Gutteridge JMC. 1991 Plasma ascorbate levels and inhibition of the antioxidant activity of caeruloplasmin. Clin Sci 81, 413-417.
8. Gutteridge JMC, Stocks J. 1981 Caeruloplasmin: physiological and pathological perspectives. CRC Crit Rev Clin Lab Med 14, 257-329.
9. Gutteridge JMC, Richmond R, Halliwell B. 1980 Oxygen free-radicals and lipid peroxidation: inhibition by the protein caeruloplasmin. FEBS Lett 112, 269-272.
10. Harris ZL, Takahashi Y, Miyajima H, et al. 1995 Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci 92, 2539-2543.
11. Johnson DA, Osaki S, Frieden E. 1967 A micromethod for the determination of ferroxidase (ceruloplasmin) in human serums. Clin Chem 13, 142-150.
12. Løvstad RA. 1974 Interaction of phenothiazine derivatives with human ceruloplasmin. Biochem Pharmacol 23, 1045-1052.
13. Morgan EH. 1979 Studies on the mechanism of iron release from transferrin. Biochim Biophys Acta 580, 312-326.
14. Osaki S. 1966 Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase (ceruloplasmin). J Biol Chem 241, 5053-5059.
15. Osaki S, Johnson DA, Frieden E. 1966 The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 241, 2746-2751.
16. Powers HJ, Loban A, Silvers K, Gibson AT. 1995 Vitamin C at concentrations observed in premature babies inhibits the ferroxidase activity of caeruloplasmin. Free Rad Res 22, 57-65.
17. Princiotto JV, Zapolski EJ. 1975 Difference between the two iron-binding sites of transferrin. Nature 255, 87-88.